BRAVE Burma Act
Summary
The BRAVE Burma Act (S.3981) is an early-stage bill that extends the sunset of existing Burma sanctions and adds reporting requirements on potential sanctions. It authorizes no direct spending and has no near-term market impact on US-listed equities.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.No direct US spending or market impact from this bill.
- 2.Bill is in earliest legislative stage; no committee action yet.
- 3.No US-listed companies are named or directly affected.
Market Implications
No market implications for US-listed equities. The bill's provisions are limited to extending existing sanctions on Burmese entities and adding reporting requirements. No US company is named or affected.
Full Analysis
-
What happened: On March 4, 2026, Senator Van Hollen introduced S.3981, the BRAVE Burma Act, which was read twice and referred to the Senate Committee on Foreign Relations. The bill is in its earliest legislative stage with no committee action or floor votes scheduled.
-
The money trail: The bill authorizes zero direct spending. It extends the sunset of the Burma Unified through Rigorous Military Accountability Act of 2022 from 8 to 10 years and requires the President to determine whether certain Burmese entities meet sanctions criteria. No US government funds are allocated or authorized.
-
Structural winners and losers: This bill targets Burmese state-owned enterprises and foreign persons operating in Burma's jet fuel sector. No US-listed companies are directly named or affected. The sanctions regime is already in place under existing law; this bill merely extends and adds reporting requirements.
-
Market data: No real market data was provided. The bill has no identifiable impact on any US-listed equity.
-
Timeline: The bill is at the referral stage. It must pass through the Senate Foreign Relations Committee, then the full Senate, then the House (where a companion bill HR3190 exists but is also at referral stage), and then be signed into law. Given the early stage and lack of committee action, passage is uncertain and likely months away at minimum.
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
African Development Foundation Termination Act of 2026
A resolution condemning the dictator of the People's Republic of China, Xi Jinping, for deceit, undermining prospects for peace and security, and orchestrating crimes against humanity.
United States Commission on International Religious Freedom Reauthorization Act of 2025
Terminate Unaccountable Spending, Abuse, Deception, and Fraud Act
Tibet Atrocities Determination Act
A resolution supporting the United States dollar as the reserve currency of the world and combating the economic influence of the People's Republic of China.
Restoring Sovereignty and Human Rights in Nicaragua Act of 2026
A resolution expressing the sense of the Senate that the President should prioritize securing the release of Pastor Jin Mingri, Pastor Gao Quanfu and his wife Pang Yu, Jimmy Lai, Dr. Gulshan Abbas, and Ekpar Asat detained by the People's Republic of China during future engagements with Chinese President Xi Jingping.
Free — no credit card
Get the next market-moving signal before the news does
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →